2009 Dosage Pharmaceutical Companies 
Pharmaceutical Technology
MAY 11, 2008
Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. Combining methods of coding for both end solutions has, in the past, been the biggest challenge. .
PharmaShots
MARCH 29, 2023
Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. No generic version of Entresto has been approved in the US.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaShots
FEBRUARY 21, 2023
The company expects to commence P-I clinical trials on metastatic and pediatric primary bone cancer patients. Other radiotherapies under the company's pipeline include Humalutin and Alpha37. The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML).
ISPE
JULY 6, 2023
Advanced technologies such as CM have the potential to greatly transform pharmaceutical production processes by improving drug quality and supply continuity for consumers worldwide while benefiting the company’s bottom line. ICH Q10 Pharmaceutical Quality System.” April 2009. November 2022. Guidance for Industry.
ISPE
JULY 6, 2023
Going up in scale, in a CONTINUUS Pharmaceuticals and MIT collaboration, an end-to-end, QbD-driven integrated continuous manufacturing (ICM) pilot plant 8 was designed to produce both small molecule active pharmaceutical ingredient (API) and oral solid dosages. In 2021, CONTINUUS Pharmaceuticals secured a$69.3
Expert insights. Personalized for you.
40 
Let's personalize your content